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The Mtv-6 provirus has an incomplete genome, but retains a functional superantigen gene (sag} which directs the thymic 
deletion of CD4 + T cells expressing T cell receptors containing the Vi83 or Vj85 chains. To better understand the Mtv-6 
superantigen, the structure and biological activity of the Mtv-6 provirus was analyzed. First, the complete nucleotide sequence 
was determined, and the mutation producing the subgenomic provirus was identified. Second, the nucleotide sequence of 
the 5' end of the sag gene transcript (including the splice junction) was determined by sequence analysis of a cDNA clone. 
Third, the superantigen activity of Mtv-6 was analyzed in mice carrying the Mtv-6 provirus isolated by selective breeding 
on a genetic background free of endogenous and exogenous mouse mammary tumor virus (MMTV). These studies demon- 
strate that (i) the Mtv-6 provirus contains a 6.2-kb deletion between two 12-bp direct repeats encompassing the central 
portion of the provirus but not affecting sag gene splicing or translation, (ii) the sag gene transcript has the structure 
predicted from previous $1 nuclease mapping studies, and (iii) the Mtv-6 superantigen can direct thymic deletion of target 
V,83 + and Vj85 + T cells in the absence of gene products from full-length MMTV proviruses. © 1995 Academic Press, Inc. 
INTRODUCTION 
Mouse mammary tumor virus (MMTV) is a replication- 
competent retrovirus that causes mammary adenocarci- 
nomas in susceptible strains of mice. MMTV is transmit- 
ted through the milk as exogenous virus or through the 
germline as integrated endogenous provirus. Most ger- 
minally transmitted MMTV proviruses are not pathogenic, 
although they typically retain residual biological function 
(e.g., virtually all retain a functional superantigen (sag) 
gene). 
The MMTV sag gene encodes the prototype retroviral 
superantigen (Acha-Orbea et al., 1991; Beutner et al., 
1992; Choi eta/., 1991). During T cell maturation, expres- 
sion of sag gene product by endogenous MMTV provi- 
ruses in antigen presenting cells results in the thymic 
deletion of CD4 + T cell subsets expressing specific V/~ 
chains in their T cell receptors (Janeway, 1991). Conse- 
quently, mature CD4 + T cells that express target V/g 
chains are depleted in the periphery. The superantigens 
from different endogenous proviruses can specifically 
engage from one to four of the 20 V/~ chains in mouse 
and segregate into various phylogenetic groups based 
on Vfl-specificity and sag gene nucleic acid sequence 
(Brandt-Oarlson et al., 1993). 
Expression of superantigen by exogenous MMTV facil- 
Sequence data from this article have been deposited with the Gen- 
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itates the dissemination of virus in vivo (Golovkina et aL, 
1992; Held et al., 1993; Pucillo et al., 1993). B cells in- 
fected during nursing are postulated to stimulate target 
T cells by expression of the sag gene product on the cell 
surface. It is not known how this stimulation affects virus 
transmission; however, disruption of superantigen func- 
tion inhibits viral spread to the mammary gland (Golov- 
kina et aL, 1992; Held et aL, 1993; Pucillo et aL, 1993). 
Superantigens from pathogenic exogenous MMTV 
strains also cause a depletion of target T cell subsets in 
the periphery, although the kinetics of T cell depletion 
are slower than with endogenous proviral superantigens 
(Ferrick et aL, 1992; Marrack et aL, 1991). 
Gene transfer experiments have demonstrated that the 
sag gene is encoded in the long open reading frame in 
the 3' LTR (Acha-Qrbea et aL, 1991; Beutner et aL, 1992; 
Choi et al., 1991; Lambert et aL, 1993), and the Vfl speci- 
ficity has been localized to the 3' end (Yazdanbakhsh 
et aL, 1993). The sag gene transcript is postulated to 
correspond to the previously identified off gene tran- 
script, a single-spliced mRNA with an intron extending 
from the splice donor site in the gag gene leader to a 
splice acceptor site just upstream of the 3' LTR (Dickson, 
1987). It has not yet been determined if the sag gene 
product is sufficient for superantigen activity or whether 
the expression of other MMTV gene products is also 
required. 
The Mtv-6 sag gene corresponds to the M/s-3 endoge- 
nous superantigen gene identified in mixed lymphocyte 
reactions between different mouse strains with the same 
major histocompatibility complex haplotype (Festenstein, 
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1973). The Mtv-6/M/s-3 superantigen mediates thymic 
deletion of CD4 + T cells that express V/33 or V/35 (Frankel 
etaL, 1991; Gollob and Palmer, 1992; Pullen eta/., 1988). 
Hybridization data demonstrates that the Mtv-6 provirus 
harbors a large internal deletion (Cohen etaL, 1979), and 
the provirus has been postulated to be an integrated 
copy of a reverse-transcribed off transcript (Kozak et al., 
1987). Previous studies of Mtv-6 superantigen activity 
have been performed in mice carrying other full-length 
endogenous proviruses. Accordingly, it is not known if 
the superantigen from the defective Mtv-6 provirus re- 
quires the activity of a viral gene product(s) from a full- 
length provirus in order to function. 
In this report, structural and functional studies of the 
subgenomic Mtv-6 provirus are presented. First, the 
structure of the Mtv-6 provirus was determined by DNA 
sequence analysis of the entire provirus to test the hy- 
pothesis that Mtv-6 is derived from a reverse transcribed 
sag gene transcript. Second, the structure of the 5' end 
of the sag gene was determined by cDNA cloning and 
DNA sequence analysis to verify the proposed structure 
of the MMTV sag gene previously deduced from Sl 
nuclease mapping studies (van Ooyen et aL, 1983; 
Wheeler et a/., 1983). Third, Mtv-6 was isolated on a 
genetic background free of endogenous and exogenous 
MMTV, and the superantigen activity of the provirus was 
assessed in vivo in the absence of gene products from 
full-length endogenous proviruses. These studies dem- 
onstrate that the subgenomic Mtv-6 provirus has a 
unique structure and retains sufficient genetic informa- 
tion for independent superantigen function in vivo. 
MATERIALS AND METHODS 
Mouse strains 
BALB/c mice were obtained from the Jackson Labora- 
tory (Bar Harbor, ME). This strain carries the Mtv-6, Mtv- 
8, and Mtv-9 endogenous proviruses (Kozak eta/., 1987). 
WLC-0 mice were developed (manuscript in preparation) 
by inbreeding endogenous MMTV-free (ev-) wild mice 
from Lake Casitas, CA (Cohen eta/., 1982). The WLC-0 
colony is free of endogenous and exogenous MMTV and 
is currently in the F30 generation of brother/sister mating. 
WLC-6 mice were developed by selective breeding of 
the Mtv-6 provirus and the H-2 ~ haplotype from BALB/c 
to the WLC-0 genetic background (manuscript in prepara- 
tion). In this report, F2 segregants heterozygous at both 
the Mtv-6.and H-2 d loci (and negative for the other two 
endogenous proviruses present in BALB/c) were ana- 
lyzed. 
Cloning Mtv-6 proviral DNA 
The Mtv-6 proviral genome was subcloned from WLC- 
6 tail clip DNA in 3 fragments, (i) the 5' LTR, (ii) the 3' 
LTR, and (iii) the region spanning the two LTRs. These 
fragments were amplified by PCR using primer pairs 
pr47.LP [5'-(1) TGCCG CGCCT GCAGC AGAAA (20)-3'] 
and pr36.4 [5'-(1368) CAAGG GTCAC TTATC CGAGG 
(1349)-3'] for the 5' LTR fragment; pr36.5 [5'-(8529) 
GTCAG ATCTi- AACGT GC-Fi-C (8548)-3'] and pr47.RM 
[5'-(9901) TGCCG CAGTC GGCCG ACCTG (9882)-3'] for 
the 3' LTR fragment; and prl 6.1 [5'-(1253) GCTCG TCACT 
TATCC -I-FCAC-(1272) 3'] and pr16.8 [5'-(8625) CTAAG 
TGTAG GACAC TCTCG (8606)-3'] for the central frag- 
ment. The-sequences of the primers are based on the 
sequence of MMTV(GR) (Fasel eta/., 1982; Redmond and 
Dickson, 1983; Fasel eta/., 1983). The coordinates of the 
primers are given in parentheses and are based on the 
full-length sequence of MMTV(BR6) provirus, with posi- 
tion t assigned to the T residue at the start of the 5' 
LTR (Moore et al., 1987). Primers were purchased from 
National Biosciences, Inc. (Plymouth, MN) and Integrated 
DNA Technologies, Inc. (Coralville, IA). PCR was per- 
formed as described previously (Ferrick et aL, 1992), and 
the PCR products were cloned in the plasmid pCRII using 
the TA Cloning kit from Invitrogen, Inc. (San Diego, CA). 
Clones of each fragment were isolated from two indepen- 
dent PCR reactions, one for plus strand sequencing and 
one for minus strand sequencing, to control for possible 
mutations introduced by the PCR amplification proce- 
dure. 
Cloning Mtv-6 sag cDNA 
Total RNA was isolated from BALB/c and WLC-6 
spleen using guanidine thiocyanate as described (Chom- 
czynski and Sacchi, 1987). The 5' end of the Mtv-6 sag 
gene transcript was amplified by the 5' RACE (rapid am- 
plification of cDNA ends) procedure (Frohman et aL, 
1988) using the 5' RACE System from Life Technologies 
(Gaithersburg, MD). The cDNA synthesis and tailing 
steps were performed according to the instructions from 
the manufacturer, while previously published PCR proce- 
dures were substituted for the amplification steps (Fer- 
rick et aL, 1992). The primers used are indicated in Fig. 
3B. Briefly, 1 #g of total RNA was reverse transcribed 
using MMTV primer pr30.3 [5'-(9571) TAAAC CCTGG 
GAACC GCAAG (9552)-3'], tailed with poly(C), and then 
PCR amplified using a modified 5' RACE anchor primer 
pr24.7 [5'-GGCCA CGCGT CGACT AGTAC GGGII GGGII 
GGGII G-3'] and MM-f-V primer pr16.6 [5'-(8647) OAACC 
CC-I-I-G GCTGC -I-i-CTC (8628)-3']. Unpurified primary 
PCR products (6%) were then reamplified with fresh re- 
agents using primer pr49.4 specific for the 5' end of the 
anchor primer [5'-GGCCA CGCGT CGACT AGTAC-3'] 
and MMTV primer prl 6.8 described above. Amplification 
products were analyzed by agarose gel electrophoresis 
and ethidium bromide staining using standard proce- 
dures, and gel purified using the QIAEX Agarose Gel 
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Extraction kit from QIAGEN, Inc, (Chatsworth, CA). Iso- 
lated fragments were cloned in plasmid pCRII using the 
TA Cloning kit from Invitrogen, Inc. 
DNA sequencing 
Plasmids for sequence analysis were purified using 
the QIAGEN Plasmid Midi-preparation kit from QIAGEN, 
Inc. The sequences of the plasmid inserts were deter- 
mined using the Sequenase (Version 2.0) DNA Sequenc- 
ing kit from USB Corp. (Cleveland, OH) and both universal 
and custom primers. Custom primers for DNA sequence 
analysis were designed using the sequence of 
MMTV(GR) (Fasel eta/., 1982, 1983; Redmond and Dick- 
son, 1983). Both the plus and minus strands of the Mtv- 
6 provirus were sequenced using two clones from inde- 
pendent PCR reactions (one for the plus strand and one 
for the minus strand). The sequences of ambiguous re- 
gions (e.g., strong stops) were verified by PCR sequenc- 
ing of Mtv-6 genomic and/or plasmid DNA using the fmol 
DNA Sequencing kit from Promega Corp. (Madison, WI). 
Sequences were compiled and analyzed using PC/GENE 
software from Intelligenetics, Inc. (Mountain View, CA). 
Flow cytometry 
Lymph node cells were prepared for flow cytometric 
analysis as described previously (Ferrick et al., 1992). 
After staining with the antibodies indicated below, the 
cells were analyzed on a FAOScan-Plus flow cytometer 
from Becton-Dickinson (Mountain View, CA). A live gate 
which included only mononuclear cells was set based on 
forward and side light-scatter characteristics, and 10,000 
events were collected. Data were analyzed using the 
Lysis II software program from Becton-Dickinson. FITC- 
conjugated antibodies specific for V/g3, V/gS.1/5.2, and 
Vfll 1 were purchased from Pharmingen (San Diego, CA). 
Phycoerythrin-conjugated antibody specific for CD4 was 
purchased from Becton-Dickinson Immunocytometry 
Systems (San Jose, CA). 
RESULTS 
DNA sequence analysis of the Mtv-6 provirus 
The Mtv-6 provirus has been postulated to be derived 
from a reverse-transcribed off transcript (Kozak et aZ, 
1987). To test this hypothesis, Mtv-6 proviral DNA from 
WLC-6 mouse genomic DNA was amplified by PCR, 
cloned, and sequenced. The complete Mtv-6 nucleotide 
sequence is shown in Fig. 1. Consistent with previous 
hybridization data (Cohen et aL, 1979), the Mtv-6 provirus 
is missing most of the gag and envgenes and all of the 
pol gene. However, the structure of the provirus demon- 
strates that it is not derived from the off transcript as 
previously speculated. 
The Mtv-6 provirus is 3610 bp in length, and is missing 
6241 bp from the center of the genome relative to the 
full-length MMTV(BR6) provirus sequence (Moore et al., 
1987) (Fig. 2). Both the 5' and 3' LTRs were sequenced 
independently and are identical. The LTR sequence re- 
ported here is in substantial agreement with two pre- 
viously reported sequences of the Mtv-6 LTR open read- 
ing frame from the DBA/2 mouse strain (Korman et aL, 
1992; Pullen etaL, 1992). Mismatches with the sequence 
of Pullen et aL (Accession No. X63026) were noted at 
LTR positions 592 and 961, and a mismatch with the 
se-quence of Korman et al. (Accession No. X64554) was 
noted at position 644. In all three discordant positions, 
the sequence in this report matches one of the two Mtv- 
6(DBA/2) sag sequences. 
A comparison of the Mtv-6 sequence with the 
MMTV(BR6) sequence revealed a 12-bp direct repeat in 
the MM.TV(BR6) provirus encompassing the region miss- 
ing from the Mtv-6 provirus (Fig. 2). This repeat was pres- 
ent only once in the Mtv-6 genome at the site of the large 
internal deletion. The two MMTV(BR6) repeat sequences 
are identical at 10 of 12 bases. One repeat is located in 
the gag gene at position 2002-2013 and has the se- 
quence G__G_GAAAAGGACCA, and the other repeat is lo- 
cated in the env gene at position 8243-8254 and has 
the sequence GGGAAAGAACCA (the identical bases in 
the two repeats are underlined). The sequence in Mtv-6 
which is related to these repeats is at position 1977- 
1988 and has the sequence GGAAAAGAACCA. It is iden- 
tical at 11 of 12 bases to either of the two MM-FV(BR6) 
repeats. The Mtv-6 provirus has a structure consistent 
with a deletion between the central AAAG motifs shared 
by the direct repeats in the full-length provirus. The dis- 
crepancy in the coordinates of the MMTV(BR6) gag re- 
peat and the Mtv-6 residual repeat is due to the fact that 
the Mtv-6 LTR is 25 bp shorter than the MMTV(BR6) LTR. 
The residual repeat in Mtv-6 is indicated by underlined 
bold type in Fig. 1. 
The Mtv-6 provirus mutation falls completely within the 
sag gene intron, leaving the splicing signals intact (Fig. 
2). While the mutation does not significantly affect the 
sag gene, the pol and env genes are completely ablated, 
and the gag gene coding sequence is truncated. The 
deletion maps downstream of the pl0 matrix (MA) pro- 
2 tein, approximately ~ of the way into the pp21 phospho- 
protein upstream of the p27 capsid protein (Hizi et aL, 
1989). Translation of the truncated pp21 open reading 
frame proceeds into an env reading frame that is closed, 
terminating at a TGA stop-codon 8 aa downstream of the 
residual Mtv-6 repeat. No efforts have been made to 
detect the MA or truncated pp21 proteins in WLC-6 ani- 
mals. 
Sequence analysis of a sag cDNA clone 
The localization of the splice acceptor signal for the 
sag gene transcript is based on $1 nuclease mapping 
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0001 TGCCGCGCCT GCAGCAGAAA TGGTTGAACT CCCGAGAGTG TCCTACACTT AGGAGAGAAG 
0061 CAGCCAAGGG GTTGTTTCCC ACCAAGGACG ACCCGTCTGC GTGCACGCGG ATGAGCCCAT 
0121 CAGACAAAGA CATACTCATT CTCTGCTGCA AACTTGGCAT AGCTCTGCTT TGCCTGGGGC 
0181 TATTGGGGGA AGTTGCGGTT CGTGCTCGCA GGGCTCTCAC CCTTGATTCT TTTAATAACT 
0241 CTTCCGTGCA AGATTACAAT CTAAACGATT CGGAGAACTC GACCTTCCTC CTGGGGCAAG 
0301 GACCACAGCC AACTTCCTCT TACAAGCCAC ACCGACTTTG TCCTTCAGAA ATAGAAATAA 
0361 GAATGCTTGC TAAAAATTAT ATTTTTACCA ATGAGACCAATCCAATAGGT CGATTATTAA 
0421 TCATGATGTT AAGAAATGAA TCTTTGTCTT TTAGCACTAT ATTTACTCAA ATTCAAAGGT 
0481 TAGAAATGGG AATAGAAAAT AGAAAGAGAC GCTCAACCTC AGTTGAAGAA CAGGTGCAAG 
0541 GACTAAGGGC CTCAGGCCTA GAAGTAAAAA GGGGAAAGAG GAGTGCGCTT GTCAAAATAG 
0601 GAGACAGGTG GTGGCAACCA GGGACTTATA GGGGACCTTA CATCTACAGA CCAACAGACG 
0661 CCCCGCTACC ATATACAGGA AGATATGATT TAAATTTTGA TAGGTGGGTC ACAGTCAACG 
0721 GCTATAAAGT GTTATACAGA TCCCTCCCCT TTCGTGAAAG GCTCGCCAGA GCTAGACCTC 
0781 CTTGGTGTGT GTTGTCTCAA GAAGAAAAAG ACGACATGAAACAACAGGTA CATGATTATA 
0841 TTTATCTGGG GACAGGAATG ATACATTGGA AAGTATTTTA TAACAGTAGA GAGGAGGCCA 
0901 AAAGACATAT AATAGAACAT ATTAAGGCAT TGCCCTTAGC TTTCTAAAGT TTGCTTGCGG 
0961 CTCCCAAGGT TTAAGTAAGT TCATGGTCAC AAACTGTTCT TAAAACAAGG ATGTGAGACA 
1021 AGTGGTTTCC TGACTTGGTT.  TGGTATCAAA TGTTTTGATC TAAGCTCTGA ATGTTCTATT 
1081 CTCCTATGTT CTTTTGGAAC TTATCCAAGT CTTATGTAAA TGCTTATGTA AACCATGATA 
1141 TAAAAGAGTG CTGATTTTTT  GAGTAAACTT GCAACAGTCC TAACATACAC GTCTCGTGTG 
1201 TTTGTGTCTG TTCGCCATCC CGTCTCCGCT CGTCACTTAT CCTTCACTTT CCAGAGGGTC 
1261 CCCCCGCAGA CCCCGGTGAC CCTCAGGTCG GCCGACTGCG GCA 
5' LTR 
1304 GCTGGCG CCCGAACAGG 
1321 GACCCTCGGA TAAGTGACCC TTGTCTCTAT TTCTACTATT TGGTGTTCGT CTTGTATTGT 
1381 CTCTTTCTTG TCTGGCTATC ATCACAAGAG CGGAACGGAC TCACCACAGG GAGCTGCAGT 
1441 CCCGCCTACG GAGGAGAGGTAGGTTACGGT GAGCCATTGG ATATGGGGGT CTCGGGCTCA 
1501 AAAGGGCAGA AACTCTTCGT TTCTGTACTA CAAAGGCTCC TCTCAGAGAG GGGTCTTCAT 
1561 GTGAAAGAGA GTAGTGCAAT AGAATTTTAT CAGTTTCTGA TAAAGGTTTC TCCTTGGTTT 
1621 CCCGAAGAAG GAGGATTAAA TTTACAAGAT TGGAAAAGGG TAGGAAGAGA AATGAAGAGG 
1681 TATGCAGCGG AGCATGGGAC AGATAGCATA CCAAAACAGG CGTACCCCAT TTGGCTTCAG 
1741 TTGAGAGAGA TACTGACAGA GCAATCAGAC TTGGTTTTGC TATCCGCAGA AGCCAAATCT 
1801 GTTACCGAAG AAGAATTAGA GGAAGGTTTA ACCGGACTAC TATCAACAAG TTCACAAGAA 
1861 AAAACTTATG GGACCAGGGG AACAGCATAT GCAGAAATAG ATACAGAGGT AGGCAAGCTG 
1921 TCTGAACATA TTTATGATGA ACCATATGAA GAAAAGGAGA AGGCAAATAA AAATGAGGAA 
1981 A/%GAACCAGA GCACATTTAT TGGGCATTTG GAATGACAAT GAGATTTCAT ATAACATACA 
2041 GGAGTTAACC AACCTGATTA GTGATATGAG CAAACAACAT ATTGACGCAG TGGACCTCAG 
2101 TGGCTTGGCT CAGTCCTTTG CCAATGGAGT AAAGGCTTTA AATCCATTGG ATTGGACACA 
2161 ATATTTCATT TTTATAGGAG TTGGAGCCCT GCTTTTGGTC ATAGTACTTT TGATTTTCCC 
2221 CATTGTTTTC CAGTGCTTTG CGAAGAGCCT TGACCAAGTG CAGTCAGATC TTAACGTGCT 
2281 TCTTTTAAAA AAGAAAAAAG GGGGAAA 
2308 TGC CGCGCCTGCA GCAGAAATGG TTGAACTCCC 
2341 GAGAGTGTCC TACACTTAGG AGAGAAGCAG CCAAGGGGTT GTTTCCCACC AAGGACGACC 
2401 CGTCTGCGTG CACGCGGATG AGCCCATCAG ACAAAGACAT ACTCATTCTC TGCTGCAAAC 
2461 TTGGCATAGC TCTGCTTTGC CTGGGGCTAT TGGGGGAAGT TGCGGTTCGT GCTCGCAGGG 
2521 CTCTCACCCT TGATTCTTTT AATAACTCTT CCGTGCAAGA TTACAATCTA AACGATTCGG 
2581 AGAACTCGAC CTTCCTCCTG GGGCAAGGAC CACAGCCAAC TTCCTCTTAC AAGCCACACC 
2641 GACTTTGTCC TTCAGAAATA GAAATAAGAA TGCTTGCTAA AAATTATATT TTTACCAATG 
2701 AGACCAATCC AATAGGTCGA TTATTAATCA TGATGTTAAG AAATGAATCT TTGTCTTTTA 
2761 GCACTATATT TACTCAAATT CAAAGGTTAG AAATGGGAAT AGAAAATAGA AAGAGACGCT 
2821 CAACCTCAGT TGAAGAACAG GTGCAAGGAC TAAGGGCCTC AGGCCTAGAA GTAAAAAGGG 
2881 GAAAGAGGAG TGCGCTTGTC AAAATAGGAG ACAGGTGGTG GCAACCAGGG ACTTATAGGG 
2941 GACCTTACAT CTACAGACCA ACAGACGCCC CGCTACCATA TACAGGAAGA TATGATTTAA 
3001 ATTTTGATAG GTGGGTCACA GTCAACGGCT ATAAAGTGTT ATACAGATCC CTCCCCTTTC 
3061 GTGAAAGGCT CGCCAGAGCT AGACCTCCTT GGTGTGTGTT GTCTCAAGAA GAAAAAGACG 
3121 ACATGAAACA ACAGGTACAT GATTATATTT ATCTGGGGAC AGGAATGATA CATTGGAAAG 
3181 TATTTTATAA CAGTAGAGAG GAGGCCAAAA GACATATAAT AGAACATATT AAGGCATTGC 
3241 CCTTAGCTTT CTAAAGTTTG CTTGCGGCTC CCAAGGTTTA AGTAAGTTCA TGGTCACAAA 
3301 CTGTTCTTAA AACAAGGATG TGAGACAAGT GGTTTCCTGA CTTGGTTTGG TATCAAATGT 
3361 TTTGATCTAA GCTCTGAATG TTCTATTCTC CTATGTTCTT TTGGAACTTA TCCAAGTCTT 
3421 ATGTAAATGC TTATGTAAAC CATGATATAA AAGAGTGCTG ATTTTTTGAG TAAACTTGCA 
3481 ACAGTCCTAA CATACACGTC TCGTGTGTTT GTGTCTGTTC GCCATCCCGT CTCCGCTCGT 
3541 CACTTATCCT TCACTTTCCA GAGGGTCCCC CCGCAGACCC CGGTGACCCT CAGGTCGGCC 
3601 GACTGCGGCA 
3' LTR 
FIG. 1. DNA sequence of the Mtv-6 provirus. The complete 3610-bp nucleotide sequence of the Mtv-6 provirus is shown. Both of the 1303-bp 5' 
and 3' LTRs are boxed. The 12-bp residual repeat sequence discussed in the text is indicated in bold and underlined. In addition, the cap site at 
position 1171, the SD1 splice donor sequence at position 1457-1460, and the SA2 splice acceptor sequence at position 2231-2234 are indicated 
in bold italics. 
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SDI 
GGAAAAGGACCA 
(2002-2013) 
MMTV(BR6) 
SA2 
GGGAAAGAACCA 
(8245-8254) 
Mtv-6 
SDI SA2 
GGAAAAGAACCA 
(1977-1988) 
FIG. 2. Structure of the Mtv-6 provirus. A schematic comparison of 
the structure of the Mtv-6 provirus and the full-length MMTV(BR6) provi- 
rus is shown. The Mtv-6 provirus structure is based on the sequence 
analysis in this report. The MMTV(BR6) structure is based on the pre- 
viously published full-length sequence of MMTV(BR6) (Moore et al., 
1987). 
(van Ooyen et al., 1983; Wheeler et al., 1983). Therefore, 
the postulated structure of the transcript was confirmed 
by sequence analysis of a cDNA clone from the 5' end. 
The 5' RACE procedure was used to amplify the 5' ends 
of endogenous MMTV proviral transcripts in BALB/c and 
WLC-6 spleen RNA samples (Fig. 3A). MM-FV-specific 
minus strand primers near the 5' end of the 3' LTR (Fig. 
3B) were selected for the PCR steps to maximize the 
yield of spliced transcripts that use the splice acceptor 
site SA2 just upstream of the 3' LTR and the sag open 
reading frame. 
Bands with approximately the same size as the pre- 
dicted sag 5' RACE product (450 bp) were detectable in 
total spleen RNA from both BALB/c and WLC-6 mice 
(Fig. 3A). A clone from the BALB/c cDNA fragment was 
completely sequenced (Fig. 3C). The sequence of this 
clone indicated that it was from the Mtv-6 provirus based 
on a comparison to the Mtv-6 proviral DNA sequence 
determined above. A single mismatch at position 300 
was noted and is assumed to be a reverse transcription 
or PCR error. Polymorphisms with published sequences 
of the Mtv-8 and Mtv-9 proviruses also present in BALB/ 
c (Brandt-Oarlson et aL, 1993) confirmed that the cDNA 
clone is from Mtv-6. It is not known to what extent tran- 
scripts from the Mtv-8 and Mtv-9 proviruses are repre- 
sented in the PCR product from BALB/c spleen or if the 
relative intensity difference between the BALB/c and 
WLC-6 sag fragments is significant (Fig. 3A). In addition 
to the sag gene cDNA fragment, several other faint frag- 
ments were observed that are currently being analyzed 
(Fig. 3A). 
The Mtv-6 sag cDNA clone characterized by DNA se- 
quence analysis had the predicted structure, confirming 
the previous Iocalizations of the sag gene splice acceptor 
site (van Ooyen et al., 1983; Wheeler et aL, 1983) and 
the splice donor site in the untranslated gag gene leader 
(Majors and Varmus, 1983; Fasel ta/., 1983). The splice 
donor site (AG^GT; called SD1 in this report) is at position 
A B 
M 1 2 SDI SA2 
5' LTR " 5' LTR 
prl 6.6 ~ I 
pr30.5 ~1 ~ 
C 
0001 CAACAGTCCT AACATACACG TCTCGTGTGT TTGTGTCTGT TCGCCATCCC GTCTCCGCTC 
0061 GTCACTTATC CTTCACTTTC CAGAGGGTCC CCCCGCAGAC CCCGGTGACC TCAGGTCGG 
0121 CCGACTGCGG CAGCTGGCGC CCGAACAGGG ACCCTCGGAT AAGTGACCCT TGTCTCTATT 
0181 TCTACTATTT GGTGTTCGTC TTGTATTGTC TCTTTCTTGT CTGGCTATCA TCACAAGAGC 
0241 GGAACGGACT CACCACAGGG AGCTGCAGTC C GCCTACGG AGGAGAG 
~intron 1 
0288 TGC TTTGCGAAGG 
0301 GCCTTGACCA AGTGCAGTCA GATCTTAACG TGCTTCTTTT  AAAAAAGAAAAAAGGGGGAA 
0361 ATGCCGCGCC TGCAGCAGAA ATGGTTGAAC TCC ...... 
FiG. 3. Expression of the Mtv-6 sag gene in BALB/c and WLC-6 mice. (A) 5' RACE products from BALB/c (lane 1) and WLC-6 (lane 2) spleen RNA 
samples. Shown is 15% of the reaction product separated on a 1.5% agarose gel. The marker (lane M) is Haelll-cleaved ~X174 DNA. (B) Location 
of 5' RACE primers. The locations of the reverse transcription (pr30.3) and nested PCR (pr16.6 and pr16.8) primers are indicated schematically in 
the diagram. (C) Nucleotide sequence of the 5' end of the Mtv-6 sag gene. The actual cap site could not be distinguished from the poly(C) tail 
added to the cDNA prior to cloning. Accordingly, the sequence starts one nucleotide downstream. The sequence extends across the SD1/SA2 
splice junction and past the start of the sag open reading frame (indicated in italics and underlined). The homopolymer and primer sequences are 
not shown. 
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TABLE 1 
CLONAL DELETION OF CD4 T T CELLS EXPRESSING V/33 OR V/55 IN WLC-6 AND CONTROL MICE 
% V/33 + % V/35 + % V/311 + 
Strain No. of mice mean (±SD) mean (--SD) mean (±8D) 
WLC-0 4 6.3 (+0.2) 3.3 (+_0.5) 8.6 (+_0.8) 
F1 (BALB/c x WLO-0) 4 0.3 (±0.2) 0.2 (_+0.1) 1.2 (+_0.4) 
WLO-6 4 0.3 (+_0.1) 0.3 (+_0.2) 7.9 (+_0.4) 
1457-1460 and the splice acceptor site [CAG^T; called 
SA2 in this report) is at position 2231-2234. Both sites 
are indicated in bold italics in Fig. 1. Because the sag 
cDNAs were generated using a C-tailing step, it was not 
possible to verify the previous Sl mapping of the MMTV 
cap site (a G residue yielding a C residue in the cDNA). 
The cDNA sequence presented in Fig. 3C begins at Mtv- 
6 position 1172, one residue downstream of the cap site 
at position 1171. 
VjS-specific deletion of CD4 + T cell subsets by the 
sag(Mtv-6)/MIs-3 gene in WLC-6 mice 
To determine if the Mtv-6 superantigen requires a gene 
product(s) from a full-length provirus for superantigen 
activity in v/vo, deletion of target T cell subsets was as- 
sessed in WLC-6 mice. Peripheral CD4 + T cells express- 
ing the Vfi3, Vfi5, and V~I 1 chains were analyzed from 
WLC-6, WLC-0, and FI(BALB/c × WLC-0) mice by flow 
cytometry. The WLC-0 and F1 mice served as negative 
and positive controls, respectively. Since the F1 mice 
were heterozygous for the three BALB/c endogenous 
proviruses (Mtv-6, Mtv-& and Mtv-9), the Mtv-6 superanti- 
gen would be expected to function in these mice if a 
gene product from the full-length Mtv-8 or Mtv-9 provi- 
ruses was also required for activity. T cells expressing 
V/53 and V~5 were targets for the Mtv-6 superantigen, 
while T cells expressing V~I 1 served as a negative con- 
trol. Because Vfil 1 + T cells are also a target of the Mtv- 
8 and Mtv-9 superantigens (Dyson eta/., 1991; Woodland 
et aL, 1991), deletion of this population was expected in 
the F1 control mice. 
Lymph nodes from four female mice (approximately 8
weeks old) from each group were analyzed for expres- 
sion of V~3, V/55, and V~I 1 in the CD4 + T cell pool (Table 
1). These data demonstrate that there was no significant 
difference in the deletion of V~3 + and Vfi5 + T cells by 
the Mtv-6 superantigen in WLC-6 mice and F1 positive 
control mice. As expected, V311 + T cells were deleted 
in F~ mice but not in WLC-6 mice or the WLC-0 negative 
control mice. The flow cytometry profiles for typical WLC- 
0, F1, and WLC-6 mice are shown in Fig. 4. 
DISCUSSION 
Among the endogenous MMTV proviruses with func- 
tional superantigen genes, Mtv-6 is unique in that it is 
subgenomic. Hybridization data indicate that the provirus 
is missing a large fraction of its coding sequences (Co- 
hen et al., 1979) and led to the speculation that Mtv-6 
was derived from a reverse transcript of the off gene 
(later renamed sag) (Kozak et aL, 1987). Accordingly, the 
Mtv-6 provirus may be a simple model system for the 
study of the MMTV superantigen, and efforts were made 
to isolate the provirus on an MMTV-free genetic back- 
ground by selective breeding of the WLC-6 mouse strain. 
The Mtv-6 model was also attractive because the sag 
gene from this provirus corresponds to one of the classi- 
cal endogenous superantigen loci, MIs-3, which had 
been extensively studied (Frankel etaL, 1991; Gollob and 
Palmer, 1992; Pullen eta/., 1988). 
Three questions concerning the Mtv-6 model have 
been addressed in this report. First, the structure of the 
provirus was not known. Second, the structure of the 
MMTV sag gene transcript was based on indirect data, 
rather than direct sequence analysis. Third, it was not 
clear whether the MMTV sag gene product was sufficient 
for T cell deletion in vivo or whether other viral gene 
products were also required for this phenotype. All prior 
studies of the Mtv-6/MIs-3 superantigen were done on 
complex genetic backgrounds with multiple full-length 
endogenous proviruses. 
• The studies reported here demonstrate that the Mtv-6 
provirus is a deletion mutant rather than an integrated 
reverse transcript of the sag gene. Consequently, the 
provirus retains the splicing signals for the sag gene 
transcript as well as portions of the gag and env genes. 
One possible explanation for the observed deletion is a 
reverse transcription error during viral replication. For 
example, the Mtv-6 mutation could have arisen by re- 
verse transcriptase skipping between the direct repeats 
during viral DNA synthesis. This mechanism could have 
involved either a single template or template switching. 
Alternatively, the deletion could have arisen by DNA re- 
combination after integration, although the short region 
of homology would seem to make recombination unlikely 
in this case. 
The cDNA sequencing studies confirmed the splicing 
model for the MMTV sag gene. While the location of 
the splice donor has been directly determined by DNA 
sequence analysis of an integrated reverse-transcribed 
envtranscript (Majors and Varmus, 1983), the location of 
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Re. 4. Olonal deletion of WLC-60D4 + T ceils expressing V/~3 and V/35. T cell profiles are shown for typical WLO-0, F~ (BALB/c x WLC-0), and 
WLC-6 mice. T cells were isolated from peripheral lymph nodes of adult females and analyzed by flow cytometry for deletion of T cells expressing 
V/~3, V/35, and V/311. The histograms were generated by gating only CD4 + T cells, and the values depicted are the percentages of cells expressing 
the indicated V/~ protein. Note that the V/33 + and V/35 + T cell targets for the Mtv-6 superantigen are depleted in the WLC-6 mouse and F~ positive 
control mouse• The V/311 + T cell population is a target for the Mtv-8 and Mtv-9 superantigens, which are present in the FT positive control mouse• 
the splice acceptor had only been localized by Sl map- 
ping and inference from the proviral DNA sequence 
(van Ooyen et al., 1983; Wheeler et aL, 1983). As ex- 
pected, the Mtv-6 sag gene transcript was produced by 
splicing from SD1 at position 1458 to SA2 at position 
2234. Unspliced Mtv-6 transcripts were net detected in 
WLO-6 RNA. 
The Vfl-specific T cell deletion phenotype of the MMTV 
sag gene is well characterized. However, it has not been 
established if other viral gene products are also required 
for this effect in vivo. In the absence of other full-length 
proviruses, the pattern of Mtv-6-mediated deletions of 
CD4 ÷ T cells expressing V/g3 and V/% in WLC-6 mice 
was consistent with previous analyses of Mtv-6 in more 
complex systems (Frank@ et al., 1991; Woodland et aL, 
1991; Pullen et al., 1988). Therefore, these experiments 
rule out pc/, env, and most of the gag gene as potential 
complementing factors for T cell deletion in vivo. The 
activity of the Mtv-6 superantigen isolated in WLC-6 was 
not tested in vitro. 
Although Mtv-6 has a large 6.2-kb deletion, the provirus 
may retain additional gene products which are necessary 
for superantigen-mediated T cell deletion in v/vo. As indi- 
cated above, the provirus retains the MA protein coding 
sequence as well as most of the pp21 coding sequence. 
A role for these gag gene proteins in superantigen func- 
tion cannot be ruled out (pp21 does not have a known 
function). In addition, three Mtv-6 transcripts, from a novel 
promoter approximately 450 bp upstream of the classical 
promoter, have been identified which could potentially 
code for proteins (manuscript in preparation). Transgenic 
mouse experiments using sag expression vectors in the 
WLC-0 system are currently underway to determine if 
these residual viral functions are required for the T cell 
deletion phenotype in vivo. 
in conclusion, these studies provide a detailed analy- 
sis of the structure of the Mtv-6 provirus and demonstrate 
the utility of the new WLC-6 mouse strain for in vivo 
studies of MMTV superantigen activity. The Mtv-6 provi- 
rus was demonstrated to contair~ a unique deletion muta- 
tion which has not been previously observed in the 
MMTV system. In addition, the structure of the MMTV 
sag gene has been confirmed by sequence analysis of 
a cDNA clone from the 5' end of the Mtv-6 sag gene. 
Finally, it was determined that the subgenomic Mtv-6 
provirus retains sufficient genetic information to direct 
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deletion of target T cells in WLC-6 mice in the absence 
of other full-length proviruses. 
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